Suresh S. Ramalingam
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Suresh S. Ramalingam
Sep 10, 2024, 14:57 |
Insight
Article of the day, September 10th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 10, 2024, 11:17 |
Insight
Jennifer Marks: Our MET-working paper in collaboration with Caris Life Sciences
Jennifer Marks shared a post on X: “Our MET-working paper in collaboration with Caris Life…
Aug 7, 2024, 18:01 |
Blog
Jarushka Naidoo: Survivorship in Lung Cancer, a great theme to usher in a new era in thoracic oncology
Jarushka Naidoo shared a post by LUNGevity Foundation on X, adding: "Survivorship in Lung Cancer,…
Jul 22, 2024, 02:59 |
Blog
CtDNA Analysis on Osimertinib in FLAURA and AURA3 trials
Jarushka Naidoo shared a post on X about an article by Jhanelle Gray et al. titled…
Jun 26, 2024, 12:05 |
Insight
Piotr Wysocki: Osimertinib after radiochemotherapy improves PFS in EGFR-mutated NSCLC patients – but is it really what they need?
Piotr Wysocki recently posted on LinkedIn: "The results of the LAURA study were presented during a…
Jun 15, 2024, 15:32 |
Blog
Yüksel Ürün: As a GU oncologist my non-GU key highlights from ASCO24
Yüksel Ürün shared on X/Twitter: "As a GU oncologist my non-GU key highlights from ASCO24. 1.…
Jun 10, 2024, 00:53 |
Insight
Vijith Shetty: Osimertinib Could Alter SOC for Stage III EGFR+ NSCLC
Vijith Shetty, Associate Professor and Consultant Medical Oncologist at KS Hegde Medical Academy, shared on…
Jun 8, 2024, 16:06 |
Blog
Reflections on ASCO24 by Jill Feldman
Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…
Jun 7, 2024, 10:53 |
Blog
Drew Moghanaki: All patients getting CRT for locally advanced NSCLC must undergo EGFR testing
Drew Moghanaki shared on X/Twitter: ''This presentation by Suresh S. Ramalingam marks a historical moment…
Jun 6, 2024, 00:54 |
Blog
Discussing the practice changing LAURA trial - Two Onc Docs
Two Onc Docs shared a post on X/Twitter: ''Discussing the practice changing LAURA trial for…
Jun 6, 2024, 00:06 |
Blog
Ivy Riano: I’ll fondly remember the great panel discussion about becoming an oncologist in the US as an immigrant
Ivy Riano, Hematology and Oncology Research Chief Fellow at Dartmouth-Hitchcock, shared a post on LinkedIn: …
Jun 5, 2024, 15:09 |
Societies
15 Posts From ASCO24 Day 5 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was held from May 31st…
Jun 5, 2024, 13:16 |
Blog
Suresh S. Ramalingam: Grateful for the support from Conquer Cancer in 2006 CDA
Suresh S. Ramalingam, Executive Director Winship Cancer Institute of Emory, Professor at Emory University and…
May 24, 2024, 14:15 |
Blog
ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO
ACS Journal Cancer shared the following on X: “Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the…
May 23, 2024, 13:26 |
Blog
Aakash Desai: Here are the top 5 abstracts you don't want to miss from ASCO24
Aakash Desai, Assistant Professor at O'Neal Comprehensive Cancer Center at UAB, shared a post on LinkedIn: "Exciting…
May 20, 2024, 07:20 |
Insight
Florez Lab: ACS Journal Cancer highlights the Florez Lab's Pregnancy and Lung Cancer Registry
Florez Lab shared a post by ACS Journal Cancer, on X "Thank you to ACS…
May 14, 2024, 16:28 |
Blog
Christian Rolfo: Great editorial by Ticiana Batista and Suresh S. Ramalingam on 20 years of EGFR
Christian Rolfo, Associate Director Clinical Research Center of Thoracic Oncology at The Tisch Cancer Institute…
May 13, 2024, 09:21 |
Blog
Urs Weber: The Next Wave Forum for Young Investigators in Thoracic Oncology!
Urs Weber, Hematology/Oncology Fellow at the University of Colorado, shared on X: "Had a great…
May 8, 2024, 07:02 |
Insight
Piotr Wysocki: Immunotherapy after chemotherapy may be the right choice
Piotr Wysocki recently shared on LinkedIn: "Mariniello A. et al. published results of an important preclinical…
Feb 6, 2024, 15:26 |
Opinion
Suresh S. Ramalingam: Great to see a shift towards more early-stage diagnosis for lung cancer!
Suresh S. Ramalingam, Executive Director at Winship Cancer Institute, shared a post by ACS Journal…
Dec 20, 2023, 11:26 |
Blog
Vivek Subbiah: Excited to join as a panelist in the upcoming STAT statnews event "Cancer's Breakthrough Engine"
Vivek Subbiah shared a post on LinkedIn: "Save the Date! Excited to join as a…
Sep 2, 2023, 00:19 |
Career
Suresh S. Ramalingam: Congrats to Dr. Ajay Nooka for his well deserved appointment to this leadership role at Winship Cancer Institute of Emory.
Suresh S. Ramalingam, Executive Director Winship Cancer Institute of Emory, Professor at Emory University and Associate…
Aug 24, 2023, 18:22 |
Blog
Suresh S. Ramalingam: Great opportunity for Residents, Fellows and Junior faculty to get involved in the National Cancer Institute funded clinical research by participating in the NCTN.
Jul 17, 2023, 18:45 |
Opinion
I aspire to be like Suresh Ramalingam - Christine Lovly
I aspire to be like Suresh S. Ramalingam. The depth and breadth of his involvement…
All:
24
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube